| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
1 company
Michael Lewis last filed a Form 4 in February 2019, as Director at OCGN. Michael Lewis's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 5,258,859 shares of OCGN. Net of sales, the OCGN filings show accumulation of 538,460 shares.
Michael Lewis has 9 Form 4 filings on record from June 2015 to February 2019, all as Director at Ocugen (OCGN), 2015–2019.
The 13 reported transactions were 6 option or other derivative awards, 2 option exercises, 2 open-market purchases and 1 conversion, plus smaller numbers of other types.
There are no priced open-market purchases or sales on record, so none of these filings shows a decision to buy or sell shares in the market.
Shares as reported in the last Form 4 for each company; the most recent is from February 2019. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 10, 2018 | OCGN Ocugen, Inc. | Director, 10% Owner | Buy | 538,460 | $0.00 | - | +17.5% |